Peer-reviewedCC BY-NCChina CDC weekly
Two mRNA Platforms for Canine Rabies Vaccines: Advances, Limitations, and Field Application Prospects
- 1China Institute of Veterinary Drug Control, Beijing, China
Related
- Biomarkers for the diagnosis and management of cardiovascular-kidney-metabolic syndrome: recent advances and prospects for clinical application
- Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Based Genome Editing in Inherited Cardiovascular Diseases: Therapeutic Advances, Emerging Editing Platforms, and Translational Challenges
- Advances in Diagnostic Testing for Eosinophilic Esophagitis: Current Approaches, Limitations, and Emerging Technologies
- Animal models of anemia of inflammation: Methodological advances, limitations, and translational applications
- Viral Platforms and Synthetic Nanoparticles in Transforming CAR-T Cell Therapy: A Review of Recent Experimental Advances in Enhancing Safety and Efficacy
BibTeX
@article{wang2026mrna,
title = {{Two mRNA Platforms for Canine Rabies Vaccines: Advances, Limitations, and Field Application Prospects}},
author = {Xi Wang and Shaozong Guo and Youheng Jiang and Suhui Wang and Yuzhu Gong and Jige Du and Chunsheng Yin},
journal = {China CDC weekly},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13673386},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Two mRNA Platforms for Canine Rabies Vaccines: Advances, Limitations, and Field Application Prospects
AU - Xi Wang
AU - Shaozong Guo
AU - Youheng Jiang
AU - Suhui Wang
AU - Yuzhu Gong
AU - Jige Du
AU - Chunsheng Yin
PY - 2026
DA - 2026/09/25
JO - China CDC weekly
UR - https://europepmc.org/article/PMC/PMC13673386
SN - 2096-7071
ER -